Company Filing History:
2 out of 51 
2 out of 50 
2 out of 50 
Years Active: 2019-2020
Title: Innovations in Cancer Therapy: The Contributions of Manal Alaamery
Introduction: Manal Alaamery is a prominent inventor based in Riyadh, Saudi Arabia, known for her significant contributions to the field of pharmaceutical technology and cancer treatment. With two patents to her name, she is pushing the boundaries of innovation in targeting and delivering therapeutic agents to cancer cells efficiently.
Latest Patents: Alaamery's latest inventions focus on developing nanoparticles designed for targeted delivery of cancer therapeutics. Her first patent outlines a method for delivering pharmaceutical nanoparticles that feature a unique membrane composed of polylactide-block-poly(ethylene glycol)-block-polylactide (PLA-PEG-PLA) integrated with polyvinyl alcohol. These nanoparticles are engineered to encapsulate a breast cancer therapeutic agent within their membranes, enhanced by a targeting group and bovine serum albumin on their exterior. Additionally, her invention describes a variant that incorporates an anti-Her2 antibody, directing treatment specifically to cells overexpressing the Her2 protein, a common feature in aggressive breast cancers.
The second patent elaborates on the principles of sustained release of the therapeutic agents from these PLA-PEG-PLA nanoparticles, maintaining efficacy over extended periods. This formulation also emphasizes the molecular weight ranges of the PEG and PLA blocks, optimizing the nanoparticle’s performance in clinical applications.
Career Highlights: Manal Alaamery's experience includes notable positions at the National Guard Health Affairs and King Saud Bin Abdulaziz University for Health Sciences. Her work within these prestigious organizations has positioned her at the forefront of health sciences research, particularly in the development of innovative cancer therapies.
Collaborations: Throughout her career, Alaamery has collaborated with skilled professionals, including her coworker Salam Massadeh. This teamwork has fostered an environment of shared knowledge, spurring advancements in their respective areas of expertise.
Conclusion: Manal Alaamery's contributions to cancer treatment through her patented innovations exemplify the critical intersection of science and technology. Her dedication to improving patient outcomes with targeted therapies showcases the potential for nanoparticles in modern medicine, marking her as an influential inventor in the realm of health sciences.